Abstract
As described by Warburg more than 50 years ago, tumour cells maintain a high glycolytic rate even in conditions of adequate oxygen supply. However, most of tumours are subjected to hypoxic conditions due to the abnormal vasculature that supply them with oxygen and nutrients. Thus, glycolysis is essential for tumour survival and spread. A key step in controlling glycolytic rate is the conversion of fructose-6-P to fructose-1,6-P2 by 6-phosphofructo-1-kinase (PFK-1). The activity of PFK-1 is allosterically controlled by fructose-2,6-P2, the product of the enzymatic activity of a dual kinase/phosphatase family of enzymes (PFKFB1-4) that are increased in a significant number of tumour types. In turn, these enzymes are induced by hypoxia through the activation of the HIF-1 complex (hypoxia-inducible complex-1), a transcriptional activator that controls the expression of most of hypoxia-regulated genes. HIF-1 complex is overexpressed in a variety of tumours and its expression appears to correlate with poor prognosis and responses to chemo or radiotherapy. Thus, targeting PFKFB enzymes, either directly or through inhibition of HIF-1, appears as a promising approach for the treatment of certain tumours.
Similar content being viewed by others
References
Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R (2002) Cancer Res 62:5881–5887
Bando H, Atsumi T, Nishio T, Niwa H, Mishima S, Shimizu C, Yoshioka N, Bucala R, Koike T (2005) Clin Cancer Res 11:5784–5792
Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, Gottlieb E, Vousden KH (2006) Cell 126:107–120
Bosca L, Rousseau GG, Hue L (1985) Proc Natl Acad Sci USA 82:6440–6444
Brahimi-Horn C, Pouyssegur J (2006) Bull Cancer 93:E73–E80
Bui T, Thompson CB (2006) Cancer Cell 9:419–420
Bustamant E, Pedersen PL (1977) Proc Natl Acad Sci USA 74:3735–3739
Calvo MN, Bartrons R, Castano E, Perales JC, Navarro-Sabate A, Manzano A (2006) FEBS Lett 580:3308–3314
Caro J (2001) High Altitude Med Biol 2:145–154
Chance B (2005) Cancer Biol Ther 4:125–126
Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R (1999) Proc Natl Acad Sci USA 96:3047–3052
Colomer D, Vives-Corrons JL, Pujades A, Bartrons R (1987) Cancer Res 47:1859–1862
Dang CV, Semenza GL (1999) Trends Biochem Sci 24:68–72
Engel M, Mazurek S, Eigenbrodt E, Welter C (2004) J Biol Chem 279:35803–35812
Esteban MA, Maxwell PH (2005) Nat Med 11:1047–1048
Fantin VR, St-Pierre J, Leder P (2006) Cancer Cell 9:425–434
Gatenby RA, Gillies RJ (2004) Nature Rev Cancer 4:891–899
Gleadle JM, Ratcliffe PJ (1998) Mol Med Today 4:122–129
Goren N, Manzano A, Riera L, Ambrosio S, Ventura F, Bartrons R (2000) Brain Res Mol Brain Res 75:138–142
Gomez M, Manzano A, Navarro-Sabate A, Duran J, Obach M, Perales JC, Bartrons R (2005) FEBS Lett 579:357–362
Hamilton JA, Callaghan MJ, Sutherland RL, Watts CK (1997) Mol Endocrinol 11:490–502
Hardie DG (2004) J Cell Sci 117:5479–5487
Hatzivassiliou G, Andreadis C, Thompson CB (2005) Drug Discovery Today: Disease Mechanisms 2:255–262
Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE (1988) Tumour Biol 9:241–248
Hong SP, Leiper FC, Woods A, Carling D, Carlson M (2003) Proc Natl Acad Sci USA 100:8839–8843
Huang LE, Arany Z, Livingston DM, Bunn HF (1996) J Biol Chem 271:32253–32259
Hue L, Rousseau GG (1993) Adv Enzyme Regul 33:97–110
Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB (2005) Mol Cell 18:283–293
Kaelin WG (2005) Cold Spring Harbor Symp Quant Biol 70:159–166
Kim J, Dang CV (2006) Cancer Res 66:8927–8930
Kim WY, Kaelin WG Jr (2006) Semin Oncol 33:588–595
Kim J, Tchernyshyov I, Semenza GL, Dang CV (2006a) Cell Metab 3:177–185
Kim SG, Manes NP, El-Maghrabi MR, Lee YH (2006b) J Biol Chem 281:2939–2944
Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL (2004) Biochem Biophys Res Commun 324:269–275
Kole HK, Resnick RJ, Van Doren M, Racker E (1991) Arch Biochem Biophys 286:586–590
Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, Martinez D, Carnero A, Beach D (2005) Cancer Res 65:177–185
Krebs HA (1972) Essays Biochem 9:1–34
Manzano A, Rosa JL, Ventura F, Perez JX, Nadal M, Estivill X, Ambrosio S, Gil J, Bartrons R (1998) Cytogenet Cell Genet 83:214–217
Marsin AS, Bouzin C, Bertrand L, Hue L (2002) J Biol Chem 277:30778–30783
Mathupala SP, Ko YH, Pedersen PL (2006) Oncogene 25:4777–4786
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (2006) Science 312:1650–1653
Maxwell PH (2005) Semin Cell Dev Biol 16:523–530
Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Curr Opin Genet Dev 11:293–299
Mazurek S, Zwerschke W, Jansen-Durr P, Eigenbrodt E (2001) Oncogene 20:6891–6898
Metzen E, Ratcliffe PJ (2004) J Biol Chem 385:223–230
Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J (2002) J Biol Chem 277:6183–6187
Minchenko O, Opentanova I, Caro J (2003) FEBS Lett 554:264–270
Minchenko OH, Ochiai A, Opentanova IL, Ogura T, Minchenko DO, Caro J, Komisarenko SV, Esumi H (2005a) Biochimie 87:1005–1010
Minchenko OH, Opentanova IL, Ogura T, Minchenko DO, Komisarenko SV, Caro J, Esumi H (2005b) Acta Biochim Pol 52:881–888
Mole DR, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) IUBMB Life 52:43–47
Obach M, Navarro-Sabate A, Caro J, Kong X, Duran J, Gomez M, Perales JC, Ventura F, Rosa JL, Bartrons R (2004) J Biol Chem 279:53562–53570
Okar DA, Lange AJ (1999) Biofactors 10:1–14
Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ (2001) Trends Biochem Sci 26:30–35
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) Cell Metab 3:187–197
Pasteur L (1861) Comp Rend Acad Sci 52:1260–1264
Pelicano H, Martin DS, Xu RH, Huang P (2006) Oncogene 25:4633–4646
Pfeiffer T, Schuster S, Bonhoeffer S (2001) Science 292:504–507
Pozuelo Rubio M, Peggie M, Wong BH, Morrice N, MacKintosh C (2003) EMBO J 22:3514–3523
Pugh CW, Ratcliffe PJ (2003) Semin Cancer Biol 13:83–89
Rajendran JG, Mankoff DA, O’Sullivan F, Peterson LM, Schwartz DL, Conrad EU, Spence AM, Muzi M, Farwell DG, Krohn KA (2004) Clin Cancer Res 10:2245–2252
Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L (2004) Biochem J 381:561–579
Riera L, Manzano A, Navarro-Sabate A, Perales JC, Bartrons R (2002) Biochim Biophys Acta 1589:89–92
Riera L, Obach M, Navarro-Sabate A, Duran J, Perales JC, Vinals F, Rosa JL, Ventura F, Bartrons R (2003) FEBS Lett 550:23–29
Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM (2005) Nature Med 11:1306–1313
Sakai A, Kato M, Fukasawa M, Ishiguro M, Furuya E, Sakakibara R (1996) J Biochem (Tokyo) 119:506–511
Sakakibara R, Kato M, Okamura N, Nakagawa T, Komada Y, Tominaga N, Shimojo M, Fukasawa M (1997) J Biochem (Tokyo) 122:122–128
Salceda S, Caro J (1997) J Biol Chem 272:22642–22647
Schofield CJ, Ratcliffe PJ (2005) Biochem Biophys Res Commun 338:617–626
Semenza GL (2006) Expert Opin Ther Targets 10:267–280
Semenza GL (2002) Trends Mol Med 8:62–67
Staal GE, Kalff A, Heesbeen EC, van Veelen CW, Rijksen G (1987) Cancer Res 47:5047–5051
Telang S, Yalcin A, Clem AL, Bucala R, Lane AN, Eaton JW, Chesney J (2006) Oncogene 25:7225–7234
Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, Mochan E (2000) Biochem J 350:307–312
Van Schaftingen E (1987) Adv Enzymol Relat Areas Mol Biol 59:315–395
Ventura F, Ambrosio S, Bartrons R, El-Maghrabi MR, Lange AJ, Pilkis SJ (1995) Biochem Biophys Res Commun 209:1140–1148
Vousden KH, Lu X (2002) Nat Rev Cancer 2:594–604
Wallace DC (2005) Cold Spring Harb Symp Quant Biol 70:363–374
Warburg O (1956) Science 124:269–270
Williams AC, Collard TJ, Paraskeva C (1999) Oncogene 18:3199–3204
Zhou J, Brune B (2006) Cardiovascular & Hematological Agents in Medicinal Chemistry 4:189–197
Zu XL, Guppy M (2004) Biochem Biophys Res Commun 313:459–465
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bartrons, R., Caro, J. Hypoxia, glucose metabolism and the Warburg’s effect. J Bioenerg Biomembr 39, 223–229 (2007). https://doi.org/10.1007/s10863-007-9080-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-007-9080-3